Symbiotec Pharmalab Ltd IPO: What You Should Know
The global leader in corticosteroid APIs opens its Rs 1,757.30 crore mainboard issue on August 24 — 38.2% global market share in corticosteroids, 30+ years of expertise Symbiotec Pharmalab Ltd. (SPL) sits at a highly specialised corner of the global pharmaceutical value chain — the manufacture of corticosteroid and steroidal-hormone Active Pharmaceutical Ingredients (APIs). These … Read more